According to a systematic review published in the Journal of Clinical Medicine, psilocybin use is associated with a significant reduction in suicidal ideation. Researchers from over a dozen research hospitals and universities across the U.S., London and Canada analyzed data from multiple studies to assess the impact of psychedelic therapies on suicide-related outcomes. Four clinical …
Category: Cannabis Studies
Peer-reviewed studies covering cannabis and cannabis compounds.
Study: 40% of Veterans With Chronic Pain Use Cannabis to Manage Symptoms
According to the results of a new study, 40% of military veterans in the United States who suffer from chronic pain consume cannabis to treat their ailment. Published in the journal Global Advances in Integrative Medicine and Health, the study was conducted by researchers from the University of California at San Francisco and Yale University. …
Study Finds Cannabis Terpenes Effectively Treat Fibromyalgia and Post-Surgical Pain
A new government-funded study published in Pharmacology Reports has found that certain terpenes found in cannabis may provide effective relief for fibromyalgia and post-surgical pain. The research, conducted by the University of Arizona Health Sciences and funded by the National Institutes of Health, builds on prior studies demonstrating terpenes’ pain-relieving properties in models of inflammation …
The Top Cannabis Studies Published So Far in 2025
The first few months of 2025 have already yielded a wide range of notable cannabis studies, exploring everything from its medical potential in brain health and pain management, to the effects of marijuana legalization laws. Despite marijuana remaining illegal in many parts of the world and in much of the United States, researchers continue to …
Study: Cannabis Extract May Improve Insomnia in Parkinson’s Disease Patients
A new study published in Frontiers in Human Neuroscience findss that cannabis extract may help alleviate insomnia in patients with Parkinson’s disease. Conducted by researchers from Brazilian institutions including Universidade Federal de Santa Catarina, the study examined the effects of oral cannabis extract on cognition, insomnia, and daytime sleepiness in six patients with moderate Parkinson’s …
Study: Psilocin Enhances Brain Plasticity, Strengthens Nerve Cell Connections After Single Dose
A groundbreaking study from from the Hector Institute for Translational Brain Research at the Central Institute of Mental Health in Mannheim has revealed that a single dose of psilocin (the psychoactive metabolite of psilocybin) boosts brain cell growth and connectivity. The findings offer valuable insights into the neurobiological mechanisms behind the therapeutic effects of psilocybin, …
Study: 96% of Vermont Primary Care Providers Are Neutral or Agree Psychedelics Have High Therapeutic Potential
A new study published in the Journal of Psychoactive Drugs finds that 96% of Vermont primary care providers are either neutral or in agreement that psychedelics have high therapeutic potential. The research, conducted by scientists at the University of Vermont, highlights a growing openness among healthcare professionals toward the medical use of substances like psilocybin, …
Study Finds Cannabinoid-Based Supplement Improves Sleep Quality and Health Outcomes in Adults With Subthreshold Insomnia
A randomized double-blind placebo-controlled crossover trial found that a cannabinoid-based oral supplement significantly improved sleep quality, efficiency, and health-related quality of life in adults with subthreshold insomnia symptoms. Conducted by researchers from the University of North Florida and Jacksonville University, the study included 20 participants who were administered either a cannabinoid supplement (CS) or a …
Cannabinoids Improve Memory and Motor Function in Animal Model of Alzheimer’s Disease
A new study published in the Journal of Alzheimer’s Disease Reports examines the potential of the synthetic cannabinoid WIN 55,212-2 in improving cognitive and motor deficits associated with Alzheimer’s disease. The research, conducted on Tg4-42 transgenic mice, found that both preventative and therapeutic administration of WIN 55,212-2 (designed to mimic the effects of naturally derived …
Randomized, Double-Blind Trial Finds Low-Dose CBD May Enhance Opioid Pain Relief Without Increasing Adverse Effects
According to a randomized, double-blind, double-dummy human laboratory trial conducted by researchers from researchers from Johns Hopkins University School of Medicine and Arizona State University, cannabidiol (CBD) enhances the analgesic effects of the opioid hydromorphone without exacerbating its adverse effects. The study involved 31 healthy participants who attended five outpatient sessions, receiving different drug conditions: …
